LB Pharmaceuticals Inc (LBRX)

NASDAQ: LBRX · Real-Time Price · USD

42.01

+3.92 (10.29%)

At close: Nov 6, 2026, 4:00 PM EST

42.63

+0.62 (1.48%)

After-hours: Nov 6, 2026, 7:53 PM EST

LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	215.08	250.17	22.98	14.98	21.4
Short-Term Investments	188.69	45.04	5.02	28.31	-
Cash & Short-Term Investments	403.76	295.21	28	43.29	21.4
Cash Growth	28.39%	954.37%	-35.32%	102.26%	-
Prepaid Expenses	43.36	2.46	0.46	2.34	0.08
Other Current Assets	-	10.76	0.42	0.01	0.01
Total Current Assets	447.12	308.43	28.88	45.63	21.49
Property, Plant & Equipment	5.46	3.73	4.16	0.02	0
Other Long-Term Assets	0.79	0.77	0.5	-	-
Total Assets	453.37	312.93	33.53	45.66	21.49

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	6.88	2.13	2.32	1.39	0.16
Accrued Expenses	22.41	4.59	5.3	1.22	0.31
Current Portion of Leases	0.96	0.73	0.49	-	-
Total Current Liabilities	30.25	7.44	8.11	2.61	0.47
Long-Term Debt	-	-	-	-	24.15
Long-Term Leases	4.2	2.84	3.22	-	-
Other Long-Term Liabilities	1.28	1.34	2.5	1.56	18.49
Total Liabilities	35.73	11.62	13.83	4.16	43.11

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0	0	0	0	0
Additional Paid-In Capital	677.43	430.67	9.66	6.47	6.13
Retained Earnings	-259.25	-129.53	-104.32	-41.22	-34.95
Comprehensive Income & Other	-0.55	0.17	0.11	0.27	-
Total Common Equity	417.64	301.31	-94.55	-34.47	-28.81
Shareholders' Equity	417.64	301.31	19.71	41.49	-21.62
Total Liabilities & Equity	453.37	312.93	33.53	45.66	21.49

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	5.16	3.57	3.7	-	24.15
Net Cash (Debt)	398.6	291.64	24.3	43.29	-2.74
Net Cash Growth	28.24%	1100.38%	-43.88%	-	-
Net Cash Per Share	13.61	36.25	67.82	173.44	-11.87
Filing Date Shares Outstanding	32.36	28.67	0.25	0.25	0.23
Total Common Shares Outstanding	32.27	25.3	0.25	0.25	0.23
Working Capital	416.87	300.99	20.77	43.03	21.02
Book Value Per Share	12.94	11.91	-375.53	-138.11	-124.68
Tangible Book Value	417.64	301.31	-94.55	-34.47	-28.81
Tangible Book Value Per Share	12.94	11.91	-375.53	-138.11	-124.68
Machinery	-	0.51	0.47	0.03	0.01
Leasehold Improvements	-	1.49	1.49	-	-

SEC Filings: 10-K · 10-Q